P.A. De Bank et al. / Biochemical Pharmacology 69 (2005) 1187–1193
1193
[
9] Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin
G, et al. Isolation and structure of a brain constituent that binds to the
cannabinoid receptor. Science 1992;258:1946–9.
[24] Maccarrone M, Bari M, Finazzi-Agr o` A. A sensitive and specific
radiochromatographic assay of fatty acid amide hydrolase activity.
Anal Biochem 1999;267:314–8.
[
10] Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE,
Schatz AR, et al. Identification of an endogenous 2-monoglyceride,
present in canine gut, that binds to cannabinoid receptors. Biochem
Pharmacol 1995;50:83–90.
[25] Omeir RL, Chin S, Hong Y, Ahern DG, Deutsch DG. Arachidonoyl
14
ethanolamide-[1,2- C] as a substrate for anandamide amidase. Life
Sci 1995;56:1999–2005.
[26] Qin C, Lin SY, Lang WS, Goutopoulos A, Pavlopoulos S, Mauri F, et
al. Determination of anandamide amidase activity using ultraviolet-
active amine derivatives and reverse-phase high-performance liquid
chromatography. Anal Biochem 1998;261:8–15.
[
[
[
11] Deutsch DG, Chin SA. Enzymatic synthesis and degradation of
anandamide, a cannabinoid receptor agonist. Biochem Pharmacol
1993;46:791–6.
12] Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB.
Molecular characterization of an enzyme that degrades neuromodu-
latory fatty-acid amides. Nature 1996;384:83–7.
[27] Wilson SJ, Lovenberg TW, Barbier AJ. A high-throughput-compatible
assay for determining the activity of fatty acid amide hydrolase. Anal
Biochem 2003;318:270–5.
13] Boger DL, Fecik RA, Patterson JE, Miyauchi H, Patricelli MP, Cravatt
BF. Fatty acid amide hydrolase substrate specificity. Bioorg Med
Chem Lett 2000;10:2613–6.
[28] Patterson JE, Ollmann IR, Cravatt BF, Boger DL, Wong CH, Lerner
RA. Inhibition of oleamide hydrolase catalyzed hydrolysis of the
endogenous sleep-inducing lipid cis-9-octadecenamide. J Am Chem
Soc 1996;118:5938–45.
[14] Deutsch DG, Ueda N, Yamamoto S. The fatty acid amide hydrolase
(
FAAH). Prostaglandins Leukot Essent Fatty Acids 2002;66:201–10.
[29] Thumser AEA, Voysey J, Wilton DC. A fluorescence displacement
assay for the measurement of arachidonoyl ethanolamide (ananda-
mide) and oleoyl amide (octadecenoamide) hydrolysis. Biochem
Pharmacol 1997;53:433–5.
[
15] Clement AB, Hawkins EG, Lichtman AH, Cravatt BF. Increased
seizure susceptibility and proconvulsant activity of anandamide in
mice lacking fatty acid amide hydrolase. J Neurosci 2003;23:3916–23.
16] Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin
BR, et al. Supersensitivity to anandamide and enhanced endogenous
cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc
Natl Acad Sci USA 2001;98:9371–6.
[
[30] Bergmeyer HU, Beutler H. Amino acid-related compounds: ammonia.
In: Bergmeyer HU, editor. Methods of enzymatic analysis, vol. 8. New
York: Academic Press; 1985. p. 454–62.
[31] Bradford MM. A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye
binding. Anal Biochem 1976;72:248–54.
[
[
17] Lichtman AH, Hawkins EG, Griffin G, Cravatt BF. Pharmacological
activity of fatty acid amides is regulated, but not mediated, by fatty
acid amide hydrolase in vivo. J Pharmacol Exp Ther 2002;302:73–9.
18] Pertwee RG, Fernando SR, Griffin G, Abadji V, Makriyannis A. Effect
of phenylmethylsulfonyl fluoride on the potency of anandamide as an
inhibitor of electrically evoked contractions in two isolated tissue
preparations. Eur J Pharmacol 1995;272:73–8.
[32] Deutsch DG, Omeir R, Arreaza G, Salehani D, Prestwich GD, Huang
Z, et al. Methyl arachidonyl fluorophosphonate: a potent irreversible
inhibitor of anandamide amidase. Biochem Pharmacol 1997;53:255–
60.
[33] Patricelli MP, Lashuel HA, Giang DK, Kelly JW, Cravatt BF. Com-
parative characterization of a wild type and transmembrane domain-
deleted fatty acid amide hydrolase: identification of the transmem-
[
[
[
19] Gifford AN, Bruneus M, Lin SY, Goutopoulos A, Makriyannis A,
Volkow. et al. Potentiation of the action of anandamide on hippocam-
pal slices by the fatty acid amide hydrolase inhibitor, palmitylsulpho-
nyl fluoride (AM 374). Eur J Pharmacol 1999;383:9–14.
brane domain as
a site for oligomerization. Biochemistry
1998;37:15177–87.
20] Wiley JL, Dewey MA, Jefferson RG, Winckler RL, Bridgen DT,
Willoughby KA, et al. Influence of phenylmethylsulfonyl fluoride on
anandamide brain levels and pharmacological effects. Life Sci
[34] Maccarrone M, van der Stelt M, Rossi A, Veldink GA, Vliegenthart
JFG, Agrio AF. Anandamide hydrolysis by human cells in culture and
brain. J Biol Chem 1998;273:32332–9.
2000;67:1573–83.
[35] Maurelli S, Bisogno T, DePetrocellis L, Di Luccia A, Marino G, Di
Marzo V. Two novel classes of neuroactive fatty acid amides are
substrates for mouse neuroblastoma ’anandamide amidohydrolase’.
FEBS Lett 1995;377:82–6.
21] Chiang KP, Gerber AL, Sipe JC, Cravatt BF. Reduced cellular
expression and activity of the P129T mutant of human fatty acid
amide hydrolase: evidence for a link between defects in the endo-
cannabinoid system and problem drug use. Hum Mol Genet
[36] Goparaju SK, Ueda N, Yamaguchi H, Yamamoto S. Anandamide
amidohydrolase reacting with 2-arachidonoylglycerol, another canna-
binoid receptor ligand. FEBS Lett 1998;422:69–73.
2004;13:2113–9.
[
22] Maccarrone M, Bisogno T, Valensise H, Lazzarin N, Fezza F, Manna
C, et al. Low fatty acid amide hydrolase and high anandamide levels
are associated with failure to achieve an ongoing pregnancy after IVF
and embryo transfer. Mol Hum Reprod 2002;8:188–95.
[37] Quistad GB, Sparks SE, Casida JE. Fatty acid amide hydrolase
inhibition by neurotoxic organophosphorus pesticides. Toxicol Appl
Pharmacol 2001;173:48–55.
[
23] Desarnaud F, Cadas H, Piomelli D. Anandamide amidohydrolase
activity in rat brain microsomes—identification and partial character-
ization. J Biol Chem 1995;270:6030–5.
[38] Vulliez-Le Normand B, Eisel e´ JL. Determination of detergent critical
micellar concentration by solubilization of a colored dye. Anal
Biochem 1993;208:241–3.